3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Squamous Cell Carcinoma of Head and Neck
3
Small Cell Lung Carcinoma
3
Ovarian Neoplasms
3
Glioblastoma
3
Advanced Solid Tumours
3
Solid Tumors
2
Advanced Malignant Solid Neoplasm
2
Triple-negative Metastatic Breast Cancer
1
Triple Negative Breast Neoplasms
1
Rhabdomyosarcoma
1
Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma
1
Pinealoma
1
Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation
1
Neuroectodermal Tumors, Primitive
1
Neuroblastoma
1
Myelodysplastic-Myeloproliferative Diseases
1
Metastatic Pancreatic Adenocarcinoma
1
Medulloblastoma
1
Lung Neoplasms
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Laryngeal Neoplasms
1
Gliosarcoma
1
Diffuse Intrinsic Pontine Glioma
1
Colorectal Neoplasms
1
Chromosome 5q Deletion Syndrome
1
Central Nervous System Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Astrocytoma
1
Interventions
Carboplatin
69
Paclitaxel
63
Cisplatin
32
Topotecan
29
Gemcitabine
21
Docetaxel
20
Cyclophosphamide
18
Filgrastim
17
liposomal doxorubicin
15
Peripheral Blood Stem Cell Transplantation
15
Bevacizumab
14
sargramostim
11
Taxes
10
Drug Therapy
10
Therapeutics
7
Psychiatric Rehabilitation
7
Immunohistochemistry
7
Erlotinib Hydrochloride
7
Amifostine
7
Melphalan
6
Chemotherapy, Adjuvant
6
rucaparib
5
pembrolizumab
5
mirvetuximab soravtansine
5
ixabepilone
5
Surgical Procedures, Operative
5
Mass Spectrometry
5
Interleukin-12 Subunit p35
5
Flow Cytometry
5
Etoposide
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Carcinoma, Ovarian Epithelial
×
adavosertib
×
Clear all
NCT01164995
2023-09-07
M10MKO
The Netherlands Cancer Institute
Phase 2
Completed
24 enrolled